Investigating the relationship between COPD and liver disease in alpha-1 antitrypsin deficiency

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by the misfolding and accumulation of the mutant variant of alpha-1 antitrypsin (AAT) within hepatocytes, which limits its access to the circulation and exposes the lungs to protease-mediated tissue damage.

Coherus plans Humira biosimilar sale at 85% discount – Pharmaceutical Technology

Humira was AbbVie’s blockbuster drug with sales of $21.2bn in 2022. Credit: Coherus BioSciences. Coherus BioSciences has signed a US national distribution agreement with speciality

July 14, 2023

achieves further growth in the first half of 2023 and expects strong third quarter – Biotech Investments

EQS-News: Medios AG / Key word(s): Half Year Report/Half Year Results Medios AG: achieves further growth in the first half of 2023 and expects strong

August 15, 2023

BioNTech reiterates presence in Africa; WuXi eyes first Chinese vaccine plant; Chinese drugmaker blocks FDA checks

Welcome to Endpoints’ manufacturing news briefs, where we bring you essential news on new builds, collaborations, recalls, and more. This week, we look into WuXi

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.